Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2013, Article ID 907525, 7 pages
http://dx.doi.org/10.1155/2013/907525
Research Article

Synthesis, Characterization, and Anti-Inflammatory Activity of Newer Quinazolinone Analogs

1Medicinal Chemistry Division, Department of Pharmacology, L.L.R.M. Medical College, Meerut 250002, India
2Jubilant Chemsys Ltd. R & D B-34, Sector 58, Noida 201301, India

Received 24 September 2012; Revised 29 October 2012; Accepted 1 November 2012

Academic Editor: Susana Zacchino

Copyright © 2013 Chatrasal Singh Rajput and Shiwani Singhal. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kumar, S. Sharma, Archana et al., “Some new 2,3,6-trisubstituted quinazolinones as potent anti-inflammatory, analgesic and COX-II inhibitors,” Bioorganic and Medicinal Chemistry, vol. 11, no. 23, pp. 5293–5299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Maggio, G. Daidone, D. Raffa et al., “Synthesis and pharmacological study of ethyl 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-acetates,” European Journal of Medicinal Chemistry, vol. 36, no. 9, pp. 737–742, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Giri, H. M. Thaker, T. Giordano et al., “Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential anti-inflammatory agents,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2184–2189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Manivannan and S. C. Chaturvedi, “Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents,” Bioorganic and Medicinal Chemistry, vol. 19, no. 15, pp. 4520–4528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kumar, C. S. Rajput, and S. K. Bhati, “Synthesis of 3-[4-(p-chlorophenyl)-thiazol-2-yl]-2-[(substituted azetidinone/thiazolidinone)-aminomethyl]-6-bromoquinazolin-4-ones as anti-inflammatory agent,” Bioorganic and Medicinal Chemistry, vol. 15, no. 8, pp. 3089–3096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. S. Giri, H. M. Thaker, T. Giordano et al., “Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-κB and AP-1 mediated transcriptional activation: their possible utilization as anti-inflammatory and anti-cancer agents,” Bioorganic and Medicinal Chemistry, vol. 18, no. 7, pp. 2796–2808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Bansal, V. K. Srivastava, and A. Kumar, “Synthesis and anti-inflammatory activity of 1-acetyl-5-substitute daryl-3-(β-aminonaphthyl)-2-pyrazolines and β-(substitute daminoethyl) amidonaphthalenes,” European Journal of Medicinal Chemistry, vol. 36, no. 1, pp. 81–92, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Zhu, J. Wang, G. Chandrashekar, E. Smith, X. Liu, and Y. Zhang, “Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 3864–3869, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Zhu, Q. Zhang, C. Gudise, L. Wei, E. Smith, and Y. Zeng, “Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents,” Bioorganic and Medicinal Chemistry, vol. 17, no. 13, pp. 4496–4502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. P. Suresha, R. Suhas, W. Kapfo, and D. Channe Gowda, “Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials,” European Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 2530–2540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Mohameda, M. M. Kamel, E. M. Kassem, N. Abotaleb, S. I. AbdEl-Moez, and M. F. Ahmed, “Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungalactivities,” European Journal of Medicinal Chemistry, vol. 45, no. 8, pp. 3311–3319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. R. Patel and K. C. Patel, “Synthesis, antimicrobial activity and application of some novel quinazolinone based monoazo reactive dyes on various fibres,” Dyes and Pigments, vol. 90, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Kohli, S. R. Hashim, S. Vishal, M. Sharma, and A. K. Simgh, “Synthesis and antibacterial activity of quinazolinone derivatives,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 1, no. 1, pp. 163–169, 2009. View at Google Scholar
  14. N. B. Patel and J. C. Patel, “Synthesis and antimicrobial activity of Schiff bases and 2-azetidinones derived from quinazolin-4(3H)-one,” Arabian Journal of Chemistry, vol. 4, no. 4, pp. 403–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. N. Pandeya, D. Sriram, G. Nath, and E. De Clercq, “Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one,” Pharmaceutica Acta Helvetiae, vol. 74, no. 1, pp. 11–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Kumar, P. Sharma, P. Kumari, and B. Lal Kalal, “Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstituted quinazoline-4(3H)-ones,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 14, pp. 4353–4357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Zappalà, S. Grasso, N. Micale et al., “1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 24, pp. 4427–4430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Jatav, P. Mishra, S. Kashaw, and J. P. Stables, “CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones,” European Journal of Medicinal Chemistry, vol. 43, no. 9, pp. 1945–1954, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. El-Azab and K. E. H. ElTahir, “Synthesis and anticonvulsant evaluation of some new 2, 3, 8-trisubstituted-4(3H)-quinazoline derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 22, no. 1, pp. 327–333, 2012. View at Google Scholar
  20. S. K. Kashaw, V. Kashaw, P. Mishra, N. K. Jain, and J. P. Stables, “Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea,” European Journal of Medicinal Chemistry, vol. 44, no. 11, pp. 4335–4343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Cao, Y. P. Feng, Y. Y. Jiang, S. Y. Liu, G. Y. Ding, and R. T. Li, “Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 7, pp. 1915–1917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Al-Obaid, S. G. Abdel-Hamide, H. A. El-Kashef et al., “Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs,” European Journal of Medicinal Chemistry, vol. 44, no. 6, pp. 2379–2391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Bansal, V. K. Srivastava, and A. Kumar, “Newer substituted β-aminonaphthalenes as potent anti-inflammatory agents,” Arzneimittel-Forschung/Drug Research, vol. 50, no. 11, pp. 1009–1014, 2000. View at Google Scholar · View at Scopus
  24. S. K. Srivastava, S. L. Srivastava, and S. D. Srivastava, “Synthesis of new 2-chlorophenothiazinothiadiazol-2-oxoazetidines: antimicrobial and antiinflammatory agents,” Indian Journal of Chemistry B, vol. 39, no. 6, pp. 464–467, 2000. View at Google Scholar · View at Scopus
  25. A. Kumar, B. P. Jaju, and J. N. Sinha, “1-(2-carboxyhenyl)-3-chloro-4-aryl-azetidin-2-ones as potent anti-inflammatory agents,” Indian Journal of Pharmaceutical Sciences, vol. 52, no. 6, pp. 257–260, 1990. View at Google Scholar · View at Scopus
  26. R. Yadav, S. D. Srivastava, and S. K. Srivastava, “Synthesis, antimicrobial and antiinflammatory activities of 4-oxothiazolidines and their 5-arylidenes,” Indian Journal of Chemistry B, vol. 44, no. 6, pp. 1262–1266, 2005. View at Google Scholar · View at Scopus
  27. B. Goel, T. Ram, R. Tyagi et al., “2-Substituted-3-(4-bromo-2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents,” European Journal of Medicinal Chemistry, vol. 34, no. 3, pp. 265–269, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. M. T. Bogert, “Researches on quinazolines (eighteenth paper), on 2, 3-dialkyl-4-quinazolones and the products obtained by alkylating 2-alkyl-4-quinazolones (2-alkyl-4-hydroxy quinazolones),” Journal of the American Chemical Society, vol. 29, no. 4, pp. 517–536, 1907. View at Google Scholar · View at Scopus
  29. C. A. Winter, E. A. Risley, and G. W. Nuss, “Carrageenan induced oedema in hind paw of the rat an as assay for antiinflammatory drugs,” Proceedings of the Society for Experimental Biology and Medicine, vol. 111, pp. 544–550, 1962. View at Google Scholar
  30. B. A. Berkowitz, A. D. Finck, and S. H. Ngai, “Nitrous oxide analgesia: reversal by naloxone and development of tolerance,” Pharmacology and Experimental Therapeutics, vol. 203, pp. 539–547, 1977. View at Google Scholar